About Darlene Boudreaux
Form D filings for Cx Precision Medicine in 2024 list Darlene Boudreaux as executive officer.
Darlene Boudreaux first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Darlene Boudreaux in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Darlene Boudreaux works with at each company, as listed on that company's latest Form D.
Cx Precision Medicine, Inc. · Form D, Jun 26, 2024
CC
Cameron Cushman
Director
RF
Robert Ferguson
Director
DA
Danguole Altman
President and CEO, director
EL
Edward Lasater
Director
DK
Donald Keyser
Director